4.5 Article

The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Pharmacological treatment of neuropsychiatric symptoms in Alzheimer's disease: a systematic review and meta-analysis

Jun Wang et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2015)

Article Psychiatry

Placebo Response in Antipsychotic Clinical Trials A Meta-analysis

Bret R. Rutherford et al.

JAMA PSYCHIATRY (2014)

Article Medicine, General & Internal

Demystifying trial networks and network meta-analysis

Edward J. Mills et al.

BMJ-BRITISH MEDICAL JOURNAL (2013)

Article Mathematical & Computational Biology

Automating network meta-analysis

Gert van Valkenhoef et al.

RESEARCH SYNTHESIS METHODS (2012)

Article Geriatrics & Gerontology

SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study

Gareth Maher-Edwards et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2011)

Article Health Care Sciences & Services

Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial

Georgia Salanti et al.

JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)

Article Computer Science, Interdisciplinary Applications

Conducting Meta-Analyses in R with the metafor Package

Wolfgang Viechtbauer

JOURNAL OF STATISTICAL SOFTWARE (2010)

Article Health Care Sciences & Services

Evaluation of networks of randomized trials

Georgia Salanti et al.

STATISTICAL METHODS IN MEDICAL RESEARCH (2008)

Article Clinical Neurology

Rivastigmine: a placebo controlled trial of twice daily and three times daily regimens in patients with Alzheimer's disease

Howard H. Feldman et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)

Review Medicine, General & Internal

Cholinesterase inhibitors for Alzheimer's disease

J Birks

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)

Article Medicine, General & Internal

Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period

R Bullock et al.

CURRENT MEDICAL RESEARCH AND OPINION (2005)

Review Medicine, General & Internal

Pharmacological treatment of neuropsychiatric symptoms of dementia - A review of the evidence

KM Sink et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)

Article Geriatrics & Gerontology

Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease

H Brodaty et al.

DEMENTIA AND GERIATRIC COGNITIVE DISORDERS (2005)

Review Medicine, General & Internal

Placebo response in studies of major depression - Variable, substantial, and growing

BT Walsh et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)

Article Geriatrics & Gerontology

Galantamine: a randomized, double-blind, dose comparison in patients with Alzheimer's disease

D Wilkinson et al.

INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2001)

Article Clinical Neurology

A 5-month, randomized, placebo-controlled trial of galantamine in AD

PN Tariot et al.

NEUROLOGY (2000)